Literature DB >> 26497523

Structure and dynamics of IgE-receptor interactions: FcεRI and CD23/FcεRII.

Brian J Sutton1,2, Anna M Davies1,2.   

Abstract

Immunoglobulin E (IgE) is well known for its role in allergic disease, the manifestations of which are mediated through its two Fc receptors, FcεRI and CD23 (FcεRII). IgE and its interactions with these receptors are therefore potential targets for therapeutic intervention, and exciting progress has been made in this direction. Furthermore, recent structural studies of IgE-Fc, the two receptors, and of their complexes, have revealed a remarkable degree of plasticity at the IgE-CD23 interface and an even more remarkable degree of dynamic flexibility within the IgE molecule. Indeed, there is allosteric communication between the two receptor-binding sites, which we now know are located at some distance from each other in IgE-Fc (at opposite ends of the Cε3 domain). The conformational changes associated with FcεRI and CD23 binding to IgE-Fc ensure that their interactions are mutually incompatible, and it may be that this functional imperative has driven IgE to evolve such a dynamic structure. Appreciation of these new structural data has revised our view of IgE structure, shed light on the co-evolution of antibodies and their receptors, and may open up new therapeutic opportunities.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  CD23; Fc receptor; FcεRI; antibody; immunoglobulin E

Mesh:

Substances:

Year:  2015        PMID: 26497523     DOI: 10.1111/imr.12340

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  28 in total

Review 1.  Considerations for the Design of Antibody-Based Therapeutics.

Authors:  Dennis R Goulet; William M Atkins
Journal:  J Pharm Sci       Date:  2019-06-04       Impact factor: 3.534

Review 2.  Immunoglobulin Glycosylation Effects in Allergy and Immunity.

Authors:  Alexandra Epp; Kathryn C Sullivan; Andrew B Herr; Richard T Strait
Journal:  Curr Allergy Asthma Rep       Date:  2016-11       Impact factor: 4.806

Review 3.  Past, present, and future of anti-IgE biologics.

Authors:  Pascal Guntern; Alexander Eggel
Journal:  Allergy       Date:  2020-04-21       Impact factor: 13.146

4.  The discovery of IgE 50 years later.

Authors:  Thomas A E Platts-Mills; Peter W Heymann; Scott P Commins; Judith A Woodfolk
Journal:  Ann Allergy Asthma Immunol       Date:  2016-03       Impact factor: 6.347

Review 5.  Tissues: the unexplored frontier of antibody mediated immunity.

Authors:  Nicholas E Webb; Biana Bernshtein; Galit Alter
Journal:  Curr Opin Virol       Date:  2021-02-10       Impact factor: 7.090

6.  Anaphylactic or tolerant outcomes with IgE.

Authors:  Toshiaki Kawakami; Yu Kawakami
Journal:  J Allergy Clin Immunol       Date:  2019-10-28       Impact factor: 14.290

7.  Bidirectional Transport of IgE by CD23 in the Inner Ear of Patients with Meniere's Disease.

Authors:  Na Zhang; Yafeng Lyu; Jia Guo; Jiahui Liu; Yongdong Song; Zhaomin Fan; Xiaofei Li; Na Li; Daogong Zhang; Haibo Wang
Journal:  J Immunol       Date:  2022-01-19       Impact factor: 5.426

Review 8.  Bidirectional Mast Cell-Eosinophil Interactions in Inflammatory Disorders and Cancer.

Authors:  Maria Rosaria Galdiero; Gilda Varricchi; Mansour Seaf; Giancarlo Marone; Francesca Levi-Schaffer; Gianni Marone
Journal:  Front Med (Lausanne)       Date:  2017-07-24

Review 9.  Human IgG4: a structural perspective.

Authors:  Anna M Davies; Brian J Sutton
Journal:  Immunol Rev       Date:  2015-11       Impact factor: 12.988

10.  Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab.

Authors:  Anna M Davies; Elizabeth G Allan; Anthony H Keeble; Jean Delgado; Benjamin P Cossins; Alkistis N Mitropoulou; Marie O Y Pang; Tom Ceska; Andrew J Beavil; Graham Craggs; Marta Westwood; Alistair J Henry; James M McDonnell; Brian J Sutton
Journal:  J Biol Chem       Date:  2017-04-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.